+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Levodopa"

From
Carbidopa & Levodopa Tablets Market - Global Forecast 2026-2032 - Product Thumbnail Image

Carbidopa & Levodopa Tablets Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 186 Pages
  • Global
From
Levodopa Market - Global Strategic Business Report - Product Thumbnail Image

Levodopa Market - Global Strategic Business Report

  • Report
  • August 2026
  • 377 Pages
  • Global
From
Episodic Ataxia Treatment Market Report 2026 - Product Thumbnail Image

Episodic Ataxia Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Neurodegenerative Disorder Therapeutics Market Report 2026 - Product Thumbnail Image

Neurodegenerative Disorder Therapeutics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Lewy Body Dementia Treatment Market Report 2026 - Product Thumbnail Image

Lewy Body Dementia Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Parkinson's Disease Market Report 2026 - Product Thumbnail Image

Parkinson's Disease Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Catecholamines Market Report 2026 - Product Thumbnail Image

Catecholamines Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Anti-Parkinson Drugs Market Report 2026 - Product Thumbnail Image

Anti-Parkinson Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Parkinson's Disease Drugs - Global Strategic Business Report - Product Thumbnail Image

Parkinson's Disease Drugs - Global Strategic Business Report

  • Report
  • August 2026
  • 382 Pages
  • Global
From
CNS Therapeutics - Global Strategic Business Report - Product Thumbnail Image

CNS Therapeutics - Global Strategic Business Report

  • Report
  • August 2026
  • 506 Pages
  • Global
From
From
From
Lewy Body Disease - Pipeline Insight, 2026 - Product Thumbnail Image

Lewy Body Disease - Pipeline Insight, 2026

  • Drug Pipelines
  • May 2026
  • 80 Pages
  • Global
From
Parkinson's Disease Epidemiology Forecast 2026-2035 - Product Thumbnail Image

Parkinson's Disease Epidemiology Forecast 2026-2035

  • Report
  • May 2026
  • 100 Pages
  • Global
From
Parkinson's Disease Pipeline Analysis Report 2026 - Product Thumbnail Image

Parkinson's Disease Pipeline Analysis Report 2026

  • Report
  • May 2026
  • 150 Pages
  • Global
From
From
Loading Indicator

Levodopa is a drug used to treat Parkinson's disease, a neurological disorder that affects movement. It is a dopamine precursor, meaning it is converted into dopamine in the brain, which helps to reduce the symptoms of Parkinson's. Levodopa is usually taken in combination with other drugs, such as carbidopa, to increase its effectiveness. It is one of the most commonly prescribed drugs for Parkinson's, and is often the first line of treatment. Levodopa is a part of the larger Central Nervous System (CNS) drug market, which includes drugs used to treat a variety of neurological disorders. The CNS drug market is highly competitive, with many different companies offering various treatments. Some of the companies in the Levodopa market include Merck, Novartis, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more